GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID
HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL
MORTALITY: 1 YEAR FOLLOW-UP

a 2022

GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP

NGUYEN, T.N.; M.M. QURESHI; P. KLEIN; Robert MIKULÍK; H. YAMAGAMI et. al.

Základní údaje

Originální název

GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP

Název anglicky

GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP

Autoři

NGUYEN, T.N. (garant); M.M. QURESHI; P. KLEIN; Robert MIKULÍK (203 Česká republika, domácí); H. YAMAGAMI; N. ETMINAN; A. SATHYA; M. ABDALKADER; E Saxhaug KRISTOFFERSEN; O.Y. MANSOUR; J. DEMEESTERE; K. ALPAY; H. LO; O. NAGGARA; M.A. MOHLENBRUCH; M. ACAMPA; G.M. KARWACKI; S. AHMAD; T.D. MAI; C. FALUP-PECURARIU a at. ALL

Vydání

ESOC 2022, 2022

Další údaje

Jazyk

čeština

Typ výsledku

Konferenční abstrakt

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

PDF, URL

Impakt faktor

Impact factor: 6.100

Kód RIV

RIV/00216224:14110/22:00127797

Organizační jednotka

Lékařská fakulta

ISSN

DOI

https://doi.org/10.1177/23969873221094907

Klíčová slova česky

subarachnoid hemorrhage (SAH); COVID-19; ANEURYSM TREATMENT;

Klíčová slova anglicky

subarachnoid hemorrhage (SAH); COVID-19; ANEURYSM TREATMENT;

Štítky

Excelence Science, FNUSA, RIV, rivok, user, článek v časopise

Příznaky

Mezinárodní význam

Změněno: 5. 4. 2023 14:02, Mgr. Tereza Miškechová

Anotace

ORIG EN

V originále

Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.

Anglicky

Návaznosti

90128, velká výzkumná infrastruktura

Název: CZECRIN III

Citovat

NGUYEN, T.N.; M.M. QURESHI; P. KLEIN; Robert MIKULÍK; H. YAMAGAMI; N. ETMINAN; A. SATHYA; M. ABDALKADER; E Saxhaug KRISTOFFERSEN; O.Y. MANSOUR; J. DEMEESTERE; K. ALPAY; H. LO; O. NAGGARA; M.A. MOHLENBRUCH; M. ACAMPA; G.M. KARWACKI; S. AHMAD; T.D. MAI; C. FALUP-PECURARIU a at. ALL. GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP. In ESOC 2022. 2022. ISSN 2396-9873. Dostupné z: https://doi.org/10.1177/23969873221094907.

@proceedings{2244853,
   author = {Nguyen, T.N. and Qureshi, M.M. and Klein, P. and Mikulík, Robert and Yamagami, H. and Etminan, N. and Sathya, A. and Abdalkader, M. and Kristoffersen, E Saxhaug and Mansour, O.Y. and Demeestere, J. and Alpay, K. and Lo, H. and Naggara, O. and Mohlenbruch, M.A. and Acampa, M. and Karwacki, G.M. and Ahmad, S. and Mai, T.D. and FalupandPecurariu, C. and all, at.},
   booktitle = {ESOC 2022},
   doi = {https://doi.org/10.1177/23969873221094907},
   keywords = {subarachnoid hemorrhage (SAH); COVID-19; ANEURYSM TREATMENT;},
   language = {cze},
   title = {GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073159/pdf/10.1177_23969873221094907.pdf},
   year = {2022}
}

TY  - CONF
ID  - 2244853
AU  - Nguyen, T.N. - Qureshi, M.M. - Klein, P. - Mikulík, Robert - Yamagami, H. - Etminan, N. - Sathya, A. - Abdalkader, M. - Kristoffersen, E Saxhaug - Mansour, O.Y. - Demeestere, J. - Alpay, K. - Lo, H. - Naggara, O. - Mohlenbruch, M.A. - Acampa, M. - Karwacki, G.M. - Ahmad, S. - Mai, T.D. - Falup-Pecurariu, C. - all, at.
PY  - 2022
TI  - GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP
KW  - subarachnoid hemorrhage (SAH)
KW  - COVID-19
KW  - ANEURYSM TREATMENT;
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073159/pdf/10.1177_23969873221094907.pdf
N2  - Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.
ER  -

NGUYEN, T.N.; M.M. QURESHI; P. KLEIN; Robert MIKULÍK; H. YAMAGAMI; N. ETMINAN; A. SATHYA; M. ABDALKADER; E Saxhaug KRISTOFFERSEN; O.Y. MANSOUR; J. DEMEESTERE; K. ALPAY; H. LO; O. NAGGARA; M.A. MOHLENBRUCH; M. ACAMPA; G.M. KARWACKI; S. AHMAD; T.D. MAI; C. FALUP-PECURARIU a at. ALL. GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP. In \textit{ESOC 2022}. 2022. ISSN~2396-9873. Dostupné z: https://doi.org/10.1177/23969873221094907.

Přehled o publikaci